Sign in
4

Changes in Ownership

Alkermes plc. Filed Acc 0001127602-24-027044

EVP R&D, Chief Medical Officer sold 58,996 shares at $30.08 ($1,774,576)

  • EVP R&D, Chief Medical Officer acquired 43,058 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Hopkinson Craig C. · EVP R&D, Chief Medical Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-11-11 Exercise or conversion : show line 1 in the form 10b5-1 +43,058 $20.03 $862,452 142,296 D
2024-11-11 Sale : show line 2 in the form 10b5-1 −58,996 $30.08 $1,774,576 83,300 D
Open-market sales · 58,996 sh · avg $30.08 · $1,774,576

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-11-11 Exercise or conversion : show line 3 in the form 10b5-1 Employee Stock Option (Right to Buy) −43,058 129,174 D
Loading xslF345X05/form4.xml…